Bayer AG (WAR:BAY) GF Score: 44/100 (As of Jul. 06, 2026) — 14% Below Median


WAR:BAY Bayer AG WAR:BAY
44 GF Score
Price zł226.70
GF Value zł115.74
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG GF Score?

Bayer AG WAR:BAY +1.61% 44 GF Score is 44 as of Jul. 06, 2026, which is 14% below its 10-year median of 51.00. GuruFocus rates WAR:BAY with a GF Score™ of 44/100 and a GF Value™ of zł115.74 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Bayer AG has the GF Score of 44, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 6/10
3. Growth Rank : 7/10
4. GF Value Rank : 1/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Bayer AG might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bayer AG  (WAR:BAY) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Bayer AG GF Score Related Terms

WAR:BAY vs LLY, JNJ, ABBV: GF Score Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's GF Score distribution charts can be found below:

* The bar in red indicates where Bayer AG's GF Score falls into.


WAR:BAY
44GF Score
Bayer AG WAR:BAY
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 44 mean?
Bayer AG (WAR:BAY) has a GF Score of 44 as of Jul. 06, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bayer AG and its competitors. This is 14% below median its historical median of 51.00. Over the past decade, Bayer AG's GF Score has ranged from 21.00 to 68.00.
Is Bayer AG's GF Score too high?
Bayer AG's current GF Score of 44 is 14% below median its 10-year median of 51.00. Over the past 10 years, this metric has ranged from a low of 21.00 to a high of 68.00. Overall, Bayer AG has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's GF Score compare to LLY and JNJ?
Bayer AG's GF Score of 44 can be compared against companies in the Drug Manufacturers industry. Historically, Bayer AG's own GF Score has ranged from 21.00 to 68.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bayer AG and its competitors. Bayer AG's current GF Score is 44, which is 14% below median its own 10-year median of 51.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (WAR:BAY) is currently considered Significantly Overvalued. The stock's GF Value™ is zł115.74, compared to a current price of zł226.70 — trading 95.9% above its estimated fair value. The current GF Score is 44, which is 14% below median its 10-year median of 51.00. Bayer AG's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Bayer AG (WAR:BAY), the current GF Score is 44 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł226.70 is trading 95.9% above its estimated GF Value™ of zł115.74. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • GF Score: 44 (14% below median its 10-year median of 51.00)
  • GF Value™: zł115.74 vs. price of zł226.70 (95.9% above fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
44GF Score

Get the complete analysis for WAR:BAY

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł226.70
Price
zł115.74
GF Value